Lin Jiatian, Fan Xiaoqin, Chen Junhui, Xie Xina, Yu Hongjian
Department of Minimally Invasive Intervention, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
Department of Otolaryngology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, P.R. China.
Exp Ther Med. 2020 Dec;20(6):176. doi: 10.3892/etm.2020.9306. Epub 2020 Oct 9.
Colorectal cancer (CRC) is the third most common cancer in the world and its development is associated with oncogenic dysfunction. Therefore, the present study aimed to identify differentially expressed genes (DEGs) in CRC tissues and to determine the role of keratin 80 (KRT80) in CRC cell proliferation. DEGs were initially screened in 32 paired CRC tissues and matched adjacent normal tissues from RNA-Seq datasets in The Cancer Genome Atlas database using the limma package in R software. In total, 2,114 DEGs were identified, of which was discovered to be the most upregulated in CRC tissues. Moreover, increased expression levels were confirmed in tissues collected from 50 patients with CRC using reverse transcription-quantitative PCR, and its increased expression levels were significantly associated with increased lymph node and distant metastasis and a higher pathological stage. Furthermore, knockdown using siRNA decreased the viability and proliferation of CRC cells. Finally, pathway analysis revealed that the proteins co-expressed with KRT80 in CRC were enriched in the cell cycle, DNA replication, immune system, metabolism of protein and RNA, signal transduction and other cellular processes. Among them, the cell cycle and DNA replication pathways contained the highest number of the proteins identified. In conclusion, the findings of the present study suggested that KRT80 may be overexpressed in CRC tissues. Furthermore, KRT80 may be involved in the proliferation of CRC cells, which is likely through its ability to regulate the cell cycle and DNA replication pathways, thus it may serve as a potential therapeutic target for patients with CRC.
结直肠癌(CRC)是全球第三大常见癌症,其发展与致癌功能障碍相关。因此,本研究旨在鉴定CRC组织中差异表达基因(DEGs),并确定角蛋白80(KRT80)在CRC细胞增殖中的作用。首先使用R软件中的limma软件包,从癌症基因组图谱数据库的RNA-Seq数据集中筛选32对CRC组织及其匹配的相邻正常组织中的DEGs。总共鉴定出2114个DEGs,其中发现[此处原文缺失具体基因名]在CRC组织中上调最为明显。此外,使用逆转录定量PCR在50例CRC患者收集的组织中证实了其表达水平升高,且其表达水平升高与淋巴结转移和远处转移增加以及更高的病理分期显著相关。此外,使用siRNA敲低[此处原文缺失具体基因名]可降低CRC细胞的活力和增殖。最后,通路分析显示,在CRC中与KRT80共表达的蛋白质富集于细胞周期、DNA复制、免疫系统、蛋白质和RNA代谢、信号转导及其他细胞过程。其中,细胞周期和DNA复制通路中鉴定出的蛋白质数量最多。总之,本研究结果表明KRT80可能在CRC组织中过表达。此外,KRT80可能参与CRC细胞的增殖,这可能是通过其调节细胞周期和DNA复制通路的能力实现的,因此它可能成为CRC患者潜在的治疗靶点。